Oops! You got it wrong...
EXPLANATION
✔Correct answer:
A potential decrease in oxygen-carrying capacity. For a chemotherapy patient with pre-existing cardiac disease, the greatest risk for cardiac complications is a decrease in the blood's oxygen-carrying capacity, which is primarily mediated by red blood cells and hemoglobin. Chemotherapy can cause bone marrow suppression, leading to anemia, which reduces the amount of oxygen delivered to the myocardium and other tissues.
In patients with existing cardiac conditions (e.g., coronary artery disease, heart failure), a decrease in oxygen delivery can exacerbate myocardial ischemia, cause angina, arrhythmias, or worsen heart failure. This is particularly dangerous because the heart relies heavily on a constant oxygen supply to function effectively under stress.
Think of the heart as an engine that needs a steady flow of oxygen to keep running. If anemia limits that oxygen, the engine struggles, especially if it’s already damaged. Chemotherapy can cut the fuel line (oxygen), putting extra stress on an already weak engine.
For patients at risk of cardiac complications, nurses must monitor closely for anemia and signs of compromised oxygenation.
- Monitor hemoglobin and hematocrit levels regularly in chemotherapy patients.
- Assess for clinical signs of anemia: fatigue, dyspnea, tachycardia, and chest pain.
- Report significant drops in hemoglobin/hematocrit to the provider, especially in cardiac patients.
- Anticipate orders for packed red blood cell transfusions if oxygen delivery becomes critically low.
- Monitor oxygen saturation and vital signs to detect early signs of decompensation.
✘Incorrect answer options:
A reduction in white blood cell count. While a low WBC count increases the risk of infection, it is not directly related to cardiac workload or function. It’s a concern, but not the greatest risk for cardiac complications.
A possible elevation in sodium levels, leading to fluid overload. Although fluid overload can worsen heart failure, this option is speculative and less directly tied to chemotherapy than anemia is. Electrolyte disturbances do matter, but a confirmed reduction in oxygen-carrying capacity is more immediately threatening to a cardiac patient.
A decrease in hematocrit levels. While this reflects anemia, it is a measurement, not a pathophysiological factor in itself. A low hematocrit contributes to reduced oxygen-carrying capacity, which is the more appropriate and encompassing answer.
References
- Ignatavicius, D. D., Workman, M. L., Rebar, C. R., & Heimgartner, N. M. (2018). Medical-Surgical Nursing: Concepts for Interprofessional Collaborative Care. Elsevier.
- Lehne, R. A., Rosenthal, L. D., & Garrison, S. R. (2021). Pharmacology for Nursing Care (11th ed.). Elsevier.